Leiomyosarcoma of the kidney with massive thrombosis of the inferior vena cava: a clinical case and a review of the literature
DOI:
https://doi.org/10.62480/tjms.2022.vol15.pp9-16Keywords:
leiomyosarcoma of the kidney, thrombosis, vena cava inferiorAbstract
Leiomyosarcoma (LMS) is a rare malignant tumor of smooth muscle origin that usually arises from soft tissues, reduced due to smooth muscle or vessel walls of venous origin. Renal leiomyosarcomas arise from the smooth muscle tissues of the renal pelvis, renal capsule, or renal vessels, and are most commonly encountered. This article presents clinical cases of diagnosis and surgical treatment of renal leiomyosarcoma found in the renal pelvis, complicated by extended thrombosis of the vena cava inferior (VCI).
References
Hui J.Y.C. Epidemiology and etiology of sarcomas. Surg Clin North Am 2016;96(5):901–14. DOI:10.1016/j.suc.2016.05.005.
Guerrero M.A., Cross C.A., Lin P.H. et al. Inferior vena cava reconstruction using fresh inferior vena cava allograft following caval resection for leiomyosarcoma: midterm results. J Vasc Surg 2007;46(1):140–3.
Laskin W.B., Fanburg-Smith J.C., Burke A.P. et al. Leiomyosarcoma of the inferior vena cava: clinicopathologic study of 40 cases.
Am J Surg Pathol 2010;34(6):873–81.
Tilkorn D., Hauser J., Ring A. et al. Leiomyosarcoma of intravascular – a rare tumor entity: clinical pathological study of twelve cases. World J Surg Oncol 2010;8:103–10.
Niceta P, Lavengood RW, Jr, Fernandes M, Tozzo PJ.Leiomyosarcoma of kidney. Review of the literature. Urology 1974;3:270-7
Lopez-Beltra A., Menendez C.L., Montironi R., Cheng L. Rare tumors and, tumor-like conditions
in urological pathology. DOI: 10.1007/978-3-319-10253-5.
Павлов А.Ю., Гармаш С.В., Исаев Т.К. и др. Современные пред- ставления о лейомиосаркомах вен забрюшинного пространства. Обзор клинических случаев. Онкоурология 2016;12(2):92–6. [Pavlov A.Yu.,
Garmash S.V., Isaev T.K. et al. Current view: leiomyosarcoma of the veins
of the retroperitoneum. Case histories review. Onkourologiya = Cancer Urology 2016;12(2):92–6. (In Russ.)].
DOI: 10.17 650/1726-9776-2016-12-2-92-96.
WHO classification of tumours of the urinary system and male genital organs. Eds.: H. Moch, P.A. Humphrey, T.M. Ulbright, V.E. Reuter. 4th edn.
Дементьев И.О., Чайков В.С., Троянов А.В. и др. Редкая злокачественная опухоль почки – лейо- миосаркома почечной вены (клинический случай). Онкоурология 2022;18(1):143–50. DOI: 10.17650/1726-9776- 2022-18-1-143-150.
Iwata J., Fletcher C.D. Immuno- histochemical detection of cytokeratin and epithelial membrane antigen in leiomyosarcoma: a systematic study
of 100 cases. Pathol Int 2000;50(1):7–14. DOI: 10.1046/j.1440-1827.2000.01001.x.
Deyrup A.T., Montgomery E., Fisher C. Leiomyosarcoma of the kidney: a clinico- pathologic study. Am J Surg Pathol 2004;28(2): 178–82. DOI: 10.1097/00000478- 200402000-00004.
Р.А.Хвастунов, А.А. Юсифова Рак почки с массивным тромбозом нижней полой вены. Хирургическое лечение. Вестник ВолгГМУ 2017г., №2(62) DOI 10.19163/1994-9480-2017-2(62)-136-140
Кригер А.Г., Берелавичус С.В., Сон А.И. и др. Хирургическое лечение неорганных забрюшинных опухолей. Хирургия. Журнал им. Н.И. Пирогова 2017;(1):15–26. [Kriger A.G., Berelavi- chus S.V., Son A.I. et al. Surgical treatment of retroperitoneal masses. Khirurgiya. Zurnal im. N.I. Pirogova = Pirogov Russian Journal of Surgery 2017;(1):15–26. (In Russ.)]. DOI: 10.17116/hirurgia2017115-26.
Raut C.P., Pisters P.W. Review retroperitoneal sarcomas: combined-modality treatment approaches. J Surg Oncol 2006;94(1):81–7. DOI: 10.1002/jso.20543.
Young S., Amirali S., Christopher S. et al. Renal leiomyosarcoma: case report and review of the literature. World J Nephrol Urol 2015;4(2):213–7. DOI: 10.14740/wjnu214w.
Beardo P, José Ledo M, Jose Luis RC. Renal leiomyosarcoma. Rare Tumors. 2013 Sep 4;5(3):e42. doi: 10.4081/rt.2013.e42. PMID: 24179654; PMCID: PMC3804817.
Bhat G., Nelivigi G., Shivalingaiah M. et al. Primary renal leiomyosarcoma:case report and literature review/ African Journal of Urology, 2011, Vol.17,№1:15-17
Kwon Y.S., Salmasi A., Sejong C. et al. Renal leiomyosarcoma% case report and review of the literature/World Journal of nephrology and urology, 2015, Vol.4, №2:213-217
Miettinen M, Fetsch JF.Evaluation of biological potential of smooth muscle tumours. Histopathology 2006;48:97-105
Bevilacqua RG, Rogatko A, Hadju SI, Brennan MF.Pronostic factors in primary retroperitoneal soft-tissue sarcomas. Arc Surg 1991;126:328-34
Raut CP, Pisters PW.Retroperitoneal sarcomas: combined-modality treatment aproaches. J Surg Oncol 2006;94:81-7
Zafar R., Manthri S., Shurbaji M.S. Renal leiomyosarcoma. StatPearls Publishing, 2021.
Mahmood T, Agresta S, Vigil CE, et al. Phase II study of sunitinib malate, a multi-targeted tyrosin kinase inhibitor in patients with relapsed or refractory soft tissue sarcomas. Focus on three prevalent histologies: leiomyosarcoma, liposarcoma and malignant fibrous histiocytoma. Int J Cancer 2011;129:1963-9
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
User Rights
Under the Creative Commons Attribution-NonCommercial 4.0 International (CC-BY-NC), the author (s) and users are free to share (copy, distribute and transmit the contribution).
Rights of Authors
Authors retain the following rights:
1. Copyright and other proprietary rights relating to the article, such as patent rights,
2. the right to use the substance of the article in future works, including lectures and books,
3. the right to reproduce the article for own purposes, provided the copies are not offered for sale,
4. the right to self-archive the article.
